Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Relenza launched in U.K. in time for this year's flu season

Sep. 9, 1999

AS-924, a newly synthesized bifunctional ceftizoxime prodrug, shows good oral absorption

Sep. 9, 1999

Micrologix Biotech receives fast track designation for antimicrobial product

Sep. 8, 1999

Novel antibiotics targeting bacterial cell wall biosynthesis synthesized by Incara

Sep. 8, 1999

Pyrimidine derivatives from Tularik useful for CMV infections

Sep. 8, 1999

Oxazolidinones with broad-spectrum activity claimed by Bayer

Sep. 7, 1999

Orally active nucleoside prodrugs for HBV and HIV infections designed at Medivir

Sep. 7, 1999

Novel antimycotic NND-502 assessed in systemic and lung infection models

Sep. 7, 1999

GPC and Novalon collaboration for discovery of broad-spectrum antibiotics

Sep. 7, 1999

New 4-pyrrolidinylthio carbapenem with balanced spectrum chosen for further studies

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...